Interview with P.F. Bongers, Chairman, Bogin
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
Address: Fellenoord 130
5611 ZB Eindhoven,Netherlands
Tel: -2668767
Web: http://www.allergan.nl/index.htm
Allergan, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential.
Allergan is a global company that works on innovation and production of ophthalmic, neuromuscular and dermatologic drugs.
We strive to offer our customers quality and the welfare of patients to improve life.
Allergan’s portfolio of products includes some of the most inventive medicines, devices, and procedures in the world. These products empower choice for medical specialists and their patients in a variety of specialty areas to meet a diverse set of needs.
Eye diseases like glaucoma and dry eye impact the sight of millions of people each year. Neurologic disorders like cervical dystonia impair functioning and subject sufferers to chronic pain that can narrow and constrain their daily lives. Chronic conditions like psoriasis or hyperhidrosis are difficult diseases to live with, both physically and emotionally. Obesity is a worldwide epidemic growing at an alarming pace. Many of our products and medical devices are aimed at addressing these and similar conditions — some well known and widespread, others rare and frequently misdiagnosed due to lack of awareness. All, however, threaten patients’ quality of life and present treatment challenges that we are focused on overcoming.
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general manager of this Dutch affiliate.…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
When it comes to the pharmaceutical and healthcare industries in the Netherlands, the country has one of the highest generic penetration rates in Europe, it does not have a strong…
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university hospitals, and public private partnerships. Given this foundation and the size of…
Given the peculiarities of the pharmaceutical industry in the Netherlands, such as the highest generics penetration rate in Europe, a relatively small manufacturing presence and a considerably regulated market, what…
2010 was a very important year for Ferring as it marks the 60th anniversary of the company’s founding. Amongst the various commemorations this year and in hearing the collective experiences…
The Dutch affiliate of Chiesi was established in 2007 when many changes were occurring in the local industry. The new healthcare system policy went into effect and the market was…
“Two traditions one vision” was the phrase used to describe the 2005 merger that formed Daiichi Sankyo as it is today. While referring specifically to a corporate merger, its message…
Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of…
Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry. What would you say was…
See our Cookie Privacy Policy Here
